Literature DB >> 11902583

Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Richard M Peek1, Martin J Blaser.   

Abstract

Although gastric adenocarcinoma is associated with the presence of Helicobacter pylori in the stomach, only a small fraction of colonized individuals develop this common malignancy. H. pylori strain and host genotypes probably influence the risk of carcinogenesis by differentially affecting host inflammatory responses and epithelial-cell physiology. Understanding the host-microbial interactions that lead to neoplasia will improve cancer-targeted therapeutics and diagnostics, and provide mechanistic insights into other malignancies that arise within the context of microbially initiated inflammatory states.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11902583     DOI： 10.1038/nrc703

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  650 in total

1.  Phenotypic and genotypic variation in methylases involved in type II restriction-modification systems in Helicobacter pylori.

Authors:  Tohru Takata; Rahul Aras; Donald Tavakoli; Takafumi Ando; Asalia Z Olivares; Martin J Blaser
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

Review 2.  Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection.

Authors:  Tomohiro Watanabe; Naoki Asano; Atsushi Kitani; Ivan J Fuss; Tsutomu Chiba; Warren Strober
Journal:  Gut Microbes       Date:  2011 Jan-Feb

3.  Distance burning: how gut microbes promote extraintestinal cancers.

Authors:  Arlin B Rogers
Journal:  Gut Microbes       Date:  2011 Jan-Feb

4.  Differential association of RANTES-403 and IL-1B-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer.

Authors:  Juwon Kim; Jong-Won Kim; Yoonjung Kim; Kyung-A Lee
Journal:  Tumour Biol       Date:  2013-12-11

5.  Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.

Authors:  Meira Epplein; Wei Zheng; Yong-Bing Xiang; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Angelika Michel; Michael Pawlita; Qiuyin Cai; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

6.  Helicobacter pylori-induced interleukin-12 p40 expression.

Authors:  Eriko Takeshima; Koh Tomimori; Hiromitsu Teruya; Chie Ishikawa; Masachika Senba; Daniele D'Ambrosio; Fukunori Kinjo; Hitomi Mimuro; Chihiro Sasakawa; Toshiya Hirayama; Jiro Fujita; Naoki Mori
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 7.  Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

Authors:  Sarah Crawford
Journal:  Ther Adv Med Oncol       Date:  2014-03       Impact factor: 8.168

8.  The Helicobacter pylori adhesin protein HopQ exploits the dimer interface of human CEACAMs to facilitate translocation of the oncoprotein CagA.

Authors:  Daniel A Bonsor; Qing Zhao; Barbara Schmidinger; Evelyn Weiss; Jingheng Wang; Daniel Deredge; Robert Beadenkopf; Blaine Dow; Wolfgang Fischer; Dorothy Beckett; Patrick L Wintrode; Rainer Haas; Eric J Sundberg
Journal:  EMBO J       Date:  2018-05-03       Impact factor: 11.598

9.  Protein evolutionary rates correlate with expression independently of synonymous substitutions in Helicobacter pylori.

Authors:  Björn Sällström; Ramy A Arnaout; Wagied Davids; Pär Bjelkmar; Siv G E Andersson
Journal:  J Mol Evol       Date:  2006-04-01       Impact factor: 2.395

10.  The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.

Authors:  Tran T Binh; Seiji Shiota; Lam T Nguyen; Dung D Q Ho; Hai H Hoang; Long Ta; Dung T Trinh; Toshio Fujioka; Yoshio Yamaoka
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.